Premium
Tau protein liquid–liquid phase separation can initiate tau aggregation
Author(s) -
Wegmann Susanne,
Eftekharzadeh Bahareh,
Tepper Katharina,
Zoltowska Katarzyna M,
Bennett Rachel E,
Dujardin Simon,
Laskowski Pawel R,
MacKenzie Danny,
Kamath Tarun,
Commins Caitlin,
Vanderburg Charles,
Roe Allyson D,
Fan Zhanyun,
Molliex Amandine M,
HernandezVega Amayra,
Muller Daniel,
Hyman Anthony A,
Mandelkow Eckhard,
Taylor J Paul,
Hyman Bradley T
Publication year - 2018
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.15252/embj.201798049
Subject(s) - biology , separation (statistics) , phase (matter) , biophysics , physics , quantum mechanics , machine learning , computer science
Abstract The transition between soluble intrinsically disordered tau protein and aggregated tau in neurofibrillary tangles in Alzheimer's disease is unknown. Here, we propose that soluble tau species can undergo liquid–liquid phase separation ( LLPS ) under cellular conditions and that phase‐separated tau droplets can serve as an intermediate toward tau aggregate formation. We demonstrate that phosphorylated or mutant aggregation prone recombinant tau undergoes LLPS , as does high molecular weight soluble phospho‐tau isolated from human Alzheimer brain. Droplet‐like tau can also be observed in neurons and other cells. We found that tau droplets become gel‐like in minutes, and over days start to spontaneously form thioflavin‐S‐positive tau aggregates that are competent of seeding cellular tau aggregation. Since analogous LLPS observations have been made for FUS , hn RNPA 1, and TDP 43, which aggregate in the context of amyotrophic lateral sclerosis, we suggest that LLPS represents a biophysical process with a role in multiple different neurodegenerative diseases.